TELA Bio, Inc.
TELA· Nasdaq
TELATELA Bio, Inc.
Filed Nov 12, 2020 · 10-Q · 43 days after period end · 0001558370-20-013708
| Metric | Q3 2020 | Q3 2019 | Q3 2018 |
|---|---|---|---|
| Revenue | $5.31M | $3.97M | $2.21M |
| Net Income | -$7.70M | -$4.67M | -$2.81M |
| EPS Diluted | -$0.53 | -$22.58 | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
TELA Bio, Inc. · CIK 1561921 · Engraved from SEC EDGAR
ended Sep 30, 2020 · filed Nov 12, 2020 · 43 d after period end
